Clinical Trials in California

Showing 6941-6960 of 8,631 trials

Clinical Research Study to Evaluate Selegiline in the Treatment of Borderline Personality Disorder

NCT01912391

Selegiline is superior to placebo in improving psychological and physical functioning in patients with Borderline Personality Disorder.

Borderline Personality Disorder

Mood and Anxiety Research, Inc30 participantsStarted Oct 2012

Fresno, California, United States

COMPLETEDPhase 4110 miles

A Prospective, Open Label Study Evaluating Two Management Strategies on Gastrointestinal Symptoms in Patients Newly on Treatment With Pradaxa for the Prevention of Stroke and Systemic Embolism With Non-valvular Atrial Fibrillation

NCT01493557

This is a prospective and open label study that aims to enroll approximately 1200 patients with non-valvular atrial fibrillation (NVAF) not previously treated with Pradaxa® and free of gastrointestinal symptoms (GIS) for at least 2 weeks prior to enrolment. Approximately 125 sites in North America will be recruited. Patients who report GIS during the 3 month treatment period will be randomized to one of two management strategies, and data documenting the intensity and duration of the GIS will be collected.

Atrial Fibrillation

Boehringer Ingelheim1,067 participantsStarted Dec 2011

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Mobile, Alabama, United States +100 more locations

Clinical Research Study to Evaluate Selegiline in the Treatment of Borderline Personality Disorder

A Prospective, Open Label Study Evaluating Two Management Strategies on Gastrointestinal Symptoms in Patients Newly on Treatment With Pradaxa for the Prevention of Stroke and Systemic Embolism With Non-valvular Atrial Fibrillation

Find Trials by Condition in California

Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of Care

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

MK2206 in Treating Patients With Advanced Liver Cancer That Did Not Respond to Previous Therapy

PoC in Rheumatoid Arthritis With Methotrexate

Study of VX-809 Alone and in Combination With VX-770 in Cystic Fibrosis (CF) Patients Homozygous or Heterozygous for the F508del-CFTR Mutation

Investigation of the Superiority Effect of Orally Disintegrating Desmopressin Tablets to Placebo in Terms of Night Voids Reduction in Nocturia Adult Male Patients

Safety and Efficacy of Aliskiren in Pediatric Hypertensive Patients 6-17 Years of Age

Pioglitazone in Early Parkinson's Disease

Phase II, 2nd Line Melanoma - RAND Monotherapy

Study of the Anti-HCV Drug (BMS-790052) Combined With Peginterferon and Ribavirin in Patients Who Failed Prior Treatment

Phase III Hallmark QUAD: ASV+DCV+Peg+Rib (Nulls/Partials)

Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients

Self Selection Trial of Naproxen Sodium

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Burn Outcomes in Young Adult Burn Survivors

Gabapentin For the Control of Hot Flashes in Women With Breast Cancer

Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer

Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer